Slide 1Dr. Abdulkarim Alhetheel Assistant Professor College of Medicine & KKUH Viral hepatitis (B, C, D, G) Slide 2 Outline Introduction to hepatitis Characteristics…
Slide 1Phase 1/2, Multicenter, Open-label, Pharmacokinetic, Safety, Tolerability, and Antiviral Activity Study of Dolutegravir (DTG), a Novel Integrase Inhibitor, in Combination…
Slide 1 Hepatitis in Pregnancy Slide 2 Summary of physiological changes in the liver during pregnancy Increased: Blood volume and cardiac ouput rise by 35% – 50% Alkaline…
Slide 1 Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases Centers…
Slide 1 Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation J2J Global Media Training on HIV/AIDS July 14, 2010 Vienna, Austria HIV in Children:…
Slide 1 Prevalence of and Progression to Abnormal Non-Invasive Markers of Liver Disease (APRI and FIB-4) among US HIV-infected Youth Kapogiannis B, Leister E, Siberry G,…
Slide 1 International Symposium Centenary of Chagas Disease 1909. 2009 Use of Polymerase Chain Reaction (PCR) to Establish Drug Efficacy - Value and Limitations Constança…
Slide 1 Chagas Disease in the United States FDA BPAC meeting, 1 April 2009 Susan P. Montgomery, DVM MPH LCDR, USPHS Parasitic Diseases Branch Centers for Disease Control…